Nasal Polyps Clinical Research Studies

Interested in joining a clinical research trial?

We are currently conducting nasal polyps studies involving the use of biologics (complicated molecules that are manufactured within a living organism) for the treatment of bilateral (both nostrils) polyps. We are partnered with a local ENT physician who provides in-depth knowledge and expertise of nasal issues. These medications are provided at absolutely no cost, with no insurance needed. You may also be reimbursed for your time and travel and will receive care from physicians affiliated with the Clinical Research Center of Alabama.

For more information on any of the following nasal polyps clinical research studies, please contact Will O’Donnell by calling 205.209.4179 or emailing wodonnell@alabamaallergy.com

Injection

Age 19-75

AstraZeneca Nasal Polyp

The purpose of this study is to evaluate the safety and effectiveness of Benralizumab (Fasenra) in adult patients with bilateral nasal polyps.

Nasal Spray with New Device

Age 12-17

Optinose

This study is being conducted to see if OPN-375 (fluticasone propionate nasal spray with an OptiNose Exhalation Delivery System (“EDS”) that delivers drug into the nose), given at a dose of 186 mcg twice a day, is safe and effective in reducing specific nasal symptoms and the size of nasal polyps in children between the ages of 12 and 17.

Become a Participant in our Nasal Polyps Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.